Aarhus University Seal

Anders Dahl Kramer

Delays in the Diagnosis and Treatment of Tuberculous Lymphadenitis in Low-Incidence Countries: A Systematic Review

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review


Early detection and treatment of tuberculosis (TB) is essential to achieve the goals appointed in the WHO End TB Strategy. Tuberculous lymphadenitis (TBLA) is the most common manifestation of extrapulmonary TB, but the diagnosis can be challenging in low-incidence countries due to sparse and inconsistent clinical features, resulting in delay. We aimed to summarize and discuss the current literature on patient delay, health care delay, and total delay (i.e., time to first health care contact, diagnosis, and treatment) in patients with TBLA in TB low-incidence countries. A systematic review using PubMed was conducted, searching for studies set in TB low-incidence countries (defined as

Original languageEnglish
Pages (from-to)576-584
Number of pages9
Publication statusPublished - Jun 2019

    Research areas

  • Early diagnosis, Extrapulmonary tuberculosis, Lymphadenitis, Lymphadenopathy, Tuberculosis diagnosis, MANAGEMENT, ADULTS, EXTRAPULMONARY TUBERCULOSIS, ETHIOPIA, AREA, LYMPHADENOPATHY, PULMONARY TUBERCULOSIS, PATIENT, BURDEN

See relations at Aarhus University Citationformats

ID: 153196992